规格: | 5mg | 产品价格: | 930 |
---|
规格: | 10mg | 产品价格: | 1790 |
---|
规格: | 50mg | 产品价格: | 3610 |
---|
Catalog Number GC14938
Molecular Formula C15H23N5O2S
Relative Molecular Mass 337.44
CAS Registry Number 1208319-26-9
Formulation A solid
Purity ≥98%
Storage Store at -20°C
SMILES CNS(C[C@@]1([H])CC[C@@](N(C2=NC=NC3=C2C=CN3)C)([H])CC1)(=O)=O
产品描述
Description:IC50: 10 nM for JAK1Janus kinase (JAK) enzymes are involved in cell signaling pathways activated by cytokines dysregulated in allergy. PF-03394197 (Oclacitinib) is a novel Janus kinase inhibitor.In vitro: PF-03394197 inhibited JAK family members by 50% at concentrations ranging from 10 to 99 nM and did not inhibit a panel of 38 non-JAK kinases. PF-03394197 was most potent at inhibiting JAK1. PF-03394197 also inhibited the function of JAK1-dependent cytokines involved in allergy and inflammation as well as pruritus. PF-03394197 had minimal effects on cytokines which did not activate the JAK1 enzyme in cells [1]. In vivo: PF-03394197 administered orally at a dose of 0.4–0.6 mg/kg twice daily was safe and efficacious in controlling the pruritus associated with allergic dermatitis. PF-03394197 provided itch relief within 24 h that persisted through the treatment period, with over 70% of the treated dogs achieving a >50% reduction in pruritus by day 7 [2]. Clinical trial: PF-03394197 (Oclacitinib) (APOQUEL?) has recently been approved in the United States and European Union for the control or treatment of pruritus associated with allergic dermatitis and the control or treatment of AD in dogs [1].Reference:[1] Gonzales AJ, Bowman JW, Fici GJ, Zhang M, Mann DW, Mitton-Fry M. Oclacitinib (APOQUEL(?)) is a novel Janus kinase inhibitor with activity against cytokines involved in allergy. J Vet Pharmacol Ther. 2014 Aug;37(4):317-24. [2] Cosgrove SB, Wren JA, Cleaver DM, Martin DD, Walsh KF, Harfst JA, Follis SL, King VL, Boucher JF, Stegemann MR. Efficacy and safety of oclacitinib for the control of pruritus and associated skin lesions in dogs with canine allergic dermatitis. Vet Dermatol. 2013 Oct;24(5):479-e114.
更多产品信息,请点击:https://www.glpbio.cn/search.php?catalog=GC14938原装进口,PF-03394197(Oclacitinib),美国GlpBio品Pai大包装更优惠!
美国Glpbio是一家领先的小分子YZ剂、激活剂、化合物库、多肽和实验室试剂的供应商。公司经营范围广泛,产品涉及癌症、免疫学、神经科学、细胞凋亡、表观遗传学等20多个不同研究领域,拥有10000多种产品。总部位于美国加利福尼亚,营销网点遍及法国、德国、加拿大、日本、澳大利亚、新加坡、以色列等20多个国家地区,竭诚为各国的科研工作者提供优质的产品和专业的服务。
温馨提示:不可用于临床ZL。